GRP78-CAR T cells sequentially kill tumor cells and secrete cytokines with a potent anti-AML activity in vivo, this effect being improved by the Src kinases inhibitor Dasatinib [89]. This evidence concerns the gene HSPA5 and acute myeloid leukemia.